admin
Americans tired of being gouged at the pharmacy counter should be encouraged by what CMS Administrator Dr. Mehmet Oz laid out on American Agenda: the Trump administration’s health reforms are designed to wrest real savings out of a broken system, with independent estimates pointing to roughly $600 billion in relief for families and taxpayers over the coming decade. Dr. Oz — who now runs the Centers for Medicare & Medicaid Services — is sounding the alarm and promising enforcement where previous administrations hesitated.
This administration has not been content with slogans; it has issued concrete policies aimed at lowering drug prices, from an executive push for most-favored-nation pricing and voluntary pricing agreements with major manufacturers to a consumer-facing TrumpRx website linking Americans to lower cash prices. These are the kinds of muscle moves that actually challenge Big Pharma’s price-setting power rather than bowing to it.
Conservatives ought to celebrate that a Republican White House is using market leverage, transparency, and reciprocity instead of higher taxes and more Washington-wide control. Dr. Oz — a political outsider turned agency head — is the kind of no-nonsense enforcer people expected when they voted for change, and he’s backing the president’s deal-making posture with practical agency action.
Of course, the left and their Big Pharma allies will headline scare stories about innovation and access, but neutral analyses show a range of outcomes and even warn that careful implementation is needed to avoid unintended consequences. That’s all the more reason to keep pressure on Washington to hold companies accountable while shepherding reforms that expand access and cut costs for seniors and working families.
History will judge administrations by whether they deliver for everyday Americans, not by how well they protected powerful special interests. If Dr. Oz and President Trump can turn policy into real, measurable savings — and the early numbers suggest they can — patriotic conservatives should stand behind tough, honest reforms that put Americans first and end the decades-long price gouging at the pharmacy.
